1. Home
  2. SAVA vs INVZ Comparison

SAVA vs INVZ Comparison

Compare SAVA & INVZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SAVA
  • INVZ
  • Stock Information
  • Founded
  • SAVA 1998
  • INVZ 2016
  • Country
  • SAVA United States
  • INVZ Israel
  • Employees
  • SAVA N/A
  • INVZ N/A
  • Industry
  • SAVA Biotechnology: Pharmaceutical Preparations
  • INVZ Auto Parts:O.E.M.
  • Sector
  • SAVA Health Care
  • INVZ Consumer Discretionary
  • Exchange
  • SAVA Nasdaq
  • INVZ Nasdaq
  • Market Cap
  • SAVA 137.2M
  • INVZ 154.6M
  • IPO Year
  • SAVA N/A
  • INVZ N/A
  • Fundamental
  • Price
  • SAVA $1.38
  • INVZ $0.62
  • Analyst Decision
  • SAVA Buy
  • INVZ Strong Buy
  • Analyst Count
  • SAVA 3
  • INVZ 5
  • Target Price
  • SAVA $54.50
  • INVZ $3.24
  • AVG Volume (30 Days)
  • SAVA 2.2M
  • INVZ 3.3M
  • Earning Date
  • SAVA 05-09-2025
  • INVZ 05-07-2025
  • Dividend Yield
  • SAVA N/A
  • INVZ N/A
  • EPS Growth
  • SAVA N/A
  • INVZ N/A
  • EPS
  • SAVA N/A
  • INVZ N/A
  • Revenue
  • SAVA N/A
  • INVZ $24,268,000.00
  • Revenue This Year
  • SAVA N/A
  • INVZ $135.37
  • Revenue Next Year
  • SAVA N/A
  • INVZ $132.60
  • P/E Ratio
  • SAVA N/A
  • INVZ N/A
  • Revenue Growth
  • SAVA N/A
  • INVZ 16.25
  • 52 Week Low
  • SAVA $1.35
  • INVZ $0.45
  • 52 Week High
  • SAVA $42.20
  • INVZ $3.14
  • Technical
  • Relative Strength Index (RSI)
  • SAVA 23.37
  • INVZ 32.57
  • Support Level
  • SAVA $1.63
  • INVZ $0.59
  • Resistance Level
  • SAVA $1.79
  • INVZ $0.76
  • Average True Range (ATR)
  • SAVA 0.19
  • INVZ 0.05
  • MACD
  • SAVA -0.14
  • INVZ 0.02
  • Stochastic Oscillator
  • SAVA 1.76
  • INVZ 22.18

About SAVA Cassava Sciences Inc.

Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms. It is currently conducting two randomized placebo-controlled Phase 3 clinical trials of oral simufilam in patients with Alzheimer's disease dementia. It has one business segment: the development of novel drugs and diagnostics.

About INVZ Innoviz Technologies Ltd. Ordinary shares

Innoviz Technologies Ltd is a provider of solid-state LiDAR and perception solutions that feature technological breakthroughs across core components and bring enhanced vision and superior performance to enable safe autonomous driving at a mass scale. The company provides a complete and comprehensive solution for OEMs and Tier-1 partners that are developing and marketing autonomous driving vehicles to the passenger cars and other relevant markets, such as robotaxis, shuttles, delivery vehicles, buses and trucks, and other industries that require 3-dimensional high resolution sensors. Company's solutions can enable safe autonomy for industries like logistics, drones, robotics, construction and other industrial applications, agriculture, smart city, smart infrastructure, security and mapping.

Share on Social Networks: